About Enovis
Enovis (NYSE:ENOV) is a dynamic company focused on developing medical technology solutions aimed at enhancing patient outcomes and advancing the field of healthcare. The company specializes in creating innovative products and services that address the needs of patients across various medical specialties, including orthopedics and rehabilitation. With a commitment to innovation, Enovis engages in ongoing research and development projects to expand its portfolio and improve the effectiveness of medical treatments. The objective of Enovis is to make a significant impact on global healthcare by delivering advanced medical technologies that improve the quality of life for patients and streamline processes for healthcare providers. Through strategic collaborations and a dedication to excellence, Enovis strives to meet the evolving needs of the healthcare industry and contribute to the betterment of patient care worldwide.
Snapshot
Operations
Products and/or services of Enovis
- Orthopedic implants for joint replacement, offering a wide range of solutions tailored to improving patient outcomes.
- Surgical solutions and technologies designed to enhance efficiency and effectiveness in the operating room.
- Motion preservation devices, focusing on innovative treatments for spine conditions to maintain or improve mobility.
- Sports medicine products, providing advanced solutions for the treatment and prevention of sports-related injuries.
- Digital health solutions, leveraging technology to improve patient care before, during, and after surgery.
- Biologics, delivering therapies that support the body's natural healing processes, including bone grafts and tissue repair products.
Enovis executive team
- Mr. Phillip Benjamin BerrySenior VP & CFO
- Mr. Bradley J. Tandy J.D.Senior VP & Chief Legal Officer
- Ms. Patricia A. LangSenior VP & Chief Human Resources Officer
- Mr. Daniel A. PryorAdvisor
- Mr. Damien McDonaldCEO & Director
- Mr. John KlecknerVP, Controller & Chief Accounting Officer
- Mr. Oliver EngertChief Administrative Officer
- Mr. Kyle William RoseVice President of Investor Relations
- Katie SweetVice President of Corporate Communication
- Mr. Tim CzartoskiPresident of U.S. Surgical and Global Product & Enabling Technologies